Comparison of Anti–Programmed Cell Death Ligand 1 Therapy Combinations vs Sunitinib for Metastatic Renal Cell Carcinoma: A Meta-analysis

This meta-analysis of 3 randomized clinical trials evaluates the association of combined anti–PD-L1 agents with survival and response rate among patients with metastatic renal cell carcinoma.

Detalles Bibliográficos
Autores principales: Maiorano, Brigida Anna, Ciardiello, Davide, Maiello, Evaristo, Roviello, Giandomenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196874/
https://www.ncbi.nlm.nih.gov/pubmed/37200035
http://dx.doi.org/10.1001/jamanetworkopen.2023.14144
_version_ 1785044437939781632
author Maiorano, Brigida Anna
Ciardiello, Davide
Maiello, Evaristo
Roviello, Giandomenico
author_facet Maiorano, Brigida Anna
Ciardiello, Davide
Maiello, Evaristo
Roviello, Giandomenico
author_sort Maiorano, Brigida Anna
collection PubMed
description This meta-analysis of 3 randomized clinical trials evaluates the association of combined anti–PD-L1 agents with survival and response rate among patients with metastatic renal cell carcinoma.
format Online
Article
Text
id pubmed-10196874
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-101968742023-05-20 Comparison of Anti–Programmed Cell Death Ligand 1 Therapy Combinations vs Sunitinib for Metastatic Renal Cell Carcinoma: A Meta-analysis Maiorano, Brigida Anna Ciardiello, Davide Maiello, Evaristo Roviello, Giandomenico JAMA Netw Open Research Letter This meta-analysis of 3 randomized clinical trials evaluates the association of combined anti–PD-L1 agents with survival and response rate among patients with metastatic renal cell carcinoma. American Medical Association 2023-05-18 /pmc/articles/PMC10196874/ /pubmed/37200035 http://dx.doi.org/10.1001/jamanetworkopen.2023.14144 Text en Copyright 2023 Maiorano BA et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Maiorano, Brigida Anna
Ciardiello, Davide
Maiello, Evaristo
Roviello, Giandomenico
Comparison of Anti–Programmed Cell Death Ligand 1 Therapy Combinations vs Sunitinib for Metastatic Renal Cell Carcinoma: A Meta-analysis
title Comparison of Anti–Programmed Cell Death Ligand 1 Therapy Combinations vs Sunitinib for Metastatic Renal Cell Carcinoma: A Meta-analysis
title_full Comparison of Anti–Programmed Cell Death Ligand 1 Therapy Combinations vs Sunitinib for Metastatic Renal Cell Carcinoma: A Meta-analysis
title_fullStr Comparison of Anti–Programmed Cell Death Ligand 1 Therapy Combinations vs Sunitinib for Metastatic Renal Cell Carcinoma: A Meta-analysis
title_full_unstemmed Comparison of Anti–Programmed Cell Death Ligand 1 Therapy Combinations vs Sunitinib for Metastatic Renal Cell Carcinoma: A Meta-analysis
title_short Comparison of Anti–Programmed Cell Death Ligand 1 Therapy Combinations vs Sunitinib for Metastatic Renal Cell Carcinoma: A Meta-analysis
title_sort comparison of anti–programmed cell death ligand 1 therapy combinations vs sunitinib for metastatic renal cell carcinoma: a meta-analysis
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196874/
https://www.ncbi.nlm.nih.gov/pubmed/37200035
http://dx.doi.org/10.1001/jamanetworkopen.2023.14144
work_keys_str_mv AT maioranobrigidaanna comparisonofantiprogrammedcelldeathligand1therapycombinationsvssunitinibformetastaticrenalcellcarcinomaametaanalysis
AT ciardiellodavide comparisonofantiprogrammedcelldeathligand1therapycombinationsvssunitinibformetastaticrenalcellcarcinomaametaanalysis
AT maielloevaristo comparisonofantiprogrammedcelldeathligand1therapycombinationsvssunitinibformetastaticrenalcellcarcinomaametaanalysis
AT roviellogiandomenico comparisonofantiprogrammedcelldeathligand1therapycombinationsvssunitinibformetastaticrenalcellcarcinomaametaanalysis

Ejemplares similares